The association of FAT1 mutations with therapeutic outcomes in AML, especially in receiving venetoclax combination
{{output}}
Objective: The role of FAT1 mutations in acute myeloid leukemia (AML) remains unclear, particularly regarding their impact on the chemosensitivity of AML patients. To elucidate the effect of FAT1 mutations on the therapeutic outc... ...
